In the ever-evolving biopharma landscape, success hinges not just on innovation but also on a clear roadmap guiding…

Reflecting on my career and the significant societal and technological shifts during those years, I see it as split…

At the core of every successful launch lies a meticulously crafted plan, a robust governance structure, and expert…

In the not-so-distant past, physician prescribing data was essentially a commodity with limited breadth or depth for…

This past December, the FDA finalized its guidance on rare diseases with the publication Rare Diseases: Considerations…

Commercializing a pharmaceutical asset in one country is hard enough. Doing it on a global scale, with multiple country…

I grew up in the Midwest — the middle child in a large family. We were each tagged with certain labels and…

In this post-COVID era, our clients have experienced a culture shift — driven by remote work, digital transformation,…

Every horse race has a starting bell, a push to move as fast as possible, and a finish line. In many ways, the launch…

Over the past 20 years, The NemetzGroup has been involved in the launch of more than 50 different drugs and has had…